Literature DB >> 34981480

Protective Effects of Curcumin on Pulmonary Arterial Hypertension.

Fatmeh Amin1,2, Shiba Yousefvand3, Tannaz Jamialahmadi4,5, Thomas P Johnston6, Amirhossein Sahebkar7,8,9.   

Abstract

Pulmonary hypertension is one of the most common diseases among older people. This disease is usually associated with complications such as vascular changes, vascular remodeling, vasoconstriction, endothelial dysfunction, right ventricular failure, and reduction in nitric oxide availability. Many chemical drugs have been used to treat pulmonary hypertension, but result in limited efficacy and several side effects, and these medications are not always available worldwide. Various studies in traditional medicine have shown that changes in lifestyle and nutritional habits can be extremely effective in both the prevention and treatment of various diseases. One treatment method related to changing nutritional habits is the use of curcumin as a nutritional supplement. Curcumin plays an important role in treating pulmonary hypertension and positively alters the aforementioned complications.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Curcumin; Pulmonary hypertension; Turmeric

Mesh:

Substances:

Year:  2021        PMID: 34981480     DOI: 10.1007/978-3-030-73234-9_14

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  45 in total

Review 1.  NF-kappaB: a key role in inflammatory diseases.

Authors:  P P Tak; G S Firestein
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 2.  Using chemopreventive agents to enhance the efficacy of cancer therapy.

Authors:  Fazlul H Sarkar; Yiwei Li
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

Review 3.  Multiple biological activities of curcumin: a short review.

Authors:  Radha K Maheshwari; Anoop K Singh; Jaya Gaddipati; Rikhab C Srimal
Journal:  Life Sci       Date:  2006-01-18       Impact factor: 5.037

4.  Molecular mechanisms of aortic wall remodeling in response to hypertension.

Authors:  C Xu; S Lee; T M Singh; E Sho; X Li; M Sho; H Masuda; C K Zarins
Journal:  J Vasc Surg       Date:  2001-03       Impact factor: 4.268

5.  Response of the rat aortic media to hypertension. Morphological and chemical studies.

Authors:  H Wolinsky
Journal:  Circ Res       Date:  1970-04       Impact factor: 17.367

6.  Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages.

Authors:  Y Abe; S Hashimoto; T Horie
Journal:  Pharmacol Res       Date:  1999-01       Impact factor: 7.658

7.  Enalapril improves arterial elastic properties in rats with myocardial infarction.

Authors:  A Ben Driss; C Himbert; P Poitevin; M Duriez; J B Michel; B I Levy
Journal:  J Cardiovasc Pharmacol       Date:  1999-07       Impact factor: 3.105

8.  Curcumin nanoparticles: preparation, characterization, and antimicrobial study.

Authors:  Rupesh Kumar Basniwal; Harpreet Singh Buttar; V K Jain; Nidhi Jain
Journal:  J Agric Food Chem       Date:  2011-02-15       Impact factor: 5.279

Review 9.  ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association.

Authors:  Vallerie V McLaughlin; Stephen L Archer; David B Badesch; Robyn J Barst; Harrison W Farber; Jonathan R Lindner; Michael A Mathier; Michael D McGoon; Myung H Park; Robert S Rosenson; Lewis J Rubin; Victor F Tapson; John Varga; Robert A Harrington; Jeffrey L Anderson; Eric R Bates; Charles R Bridges; Mark J Eisenberg; Victor A Ferrari; Cindy L Grines; Mark A Hlatky; Alice K Jacobs; Sanjay Kaul; Robert C Lichtenberg; Jonathan R Lindner; David J Moliterno; Debabrata Mukherjee; Gerald M Pohost; Robert S Rosenson; Richard S Schofield; Samuel J Shubrooks; James H Stein; Cynthia M Tracy; Howard H Weitz; Deborah J Wesley
Journal:  Circulation       Date:  2009-03-30       Impact factor: 29.690

10.  Vascular endothelial growth factor as a non-invasive marker of pulmonary vascular remodeling in patients with bronchitis-type of COPD.

Authors:  Hiroshi Kanazawa; Kazuhisa Asai; Saeko Nomura
Journal:  Respir Res       Date:  2007-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.